Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Columbus - Presentation of Q1 Report 2024

By Michael FriisHead of Equities
Columbus

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Columbus expects to release its first-quarter results on 8 May 2024. On 15 May 2024 at 11:00, Columbus’ CEO & President Søren Krogh Knudsen and CFO Brian Iversen will present the results and answer questions from the audience.

2023 ended on a strong note with the Q4 2023 quarter delivering the highest growth throughout the year, and the full-year organic growth surpassing guidance. The Q1 2024 results will be the first indicator of whether this momentum is carried into 2024. For the full year of 2024, Columbus expects organic growth of 8-10% and margins (EBITDA) to rise to 9-10% (up from 7.6% in 2023).

Columbus is a Danish-listed global IT services and consulting company, specializing in digital transformation with a main focus in the manufacturing, retail & distribution, food & beverage, and life science industries. Headquartered in Denmark and with offices and partners across many parts of the world, Columbus advises, implements, and manages IT solutions within Cloud ERP, Application Management, Digital Commerce, Data & Analytics, Customer Experience & Engagement, Security, and Strategy & Change. The Columbus share is listed on Nasdaq Copenhagen (Ticker: COLUM).

Disclaimer: HC Andersen Capital receives payment from Columbus for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 15.14, 16 April 2024.

Recent videos

GomSpace - Strategic direction & Q&A
19.01.2026 klo 15.00 GomSpace Group
Oncopeptides, Audiocast, Investor Conference, 2026
16.01.2026 klo 10.00 Oncopeptides
Duell, Webcast, Q1'26
14.01.2026 klo 10.30 Duell
Dustin Group, Audiocast, Q1'26
14.01.2026 klo 10.00 Dustin Group
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026 klo 12.00 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.